1 / 8

Tumor markers

Tumor markers. Tumors. Benign tumors: e.g. moles, warts Malignant tumors: metastasis, called cancer. Tumor markers. CANCER: Loss of control of cellular growth NEOPLASIA: New growth TUMOUR: Swelling ONCOLOGY: Study of cancer CARCINOMA - epithelial cells SARCOMA - connective tissue

keith
Download Presentation

Tumor markers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tumor markers

  2. Tumors • Benign tumors: e.g. moles, warts • Malignant tumors: metastasis, called cancer

  3. Tumor markers • CANCER: Loss of control of cellular growth • NEOPLASIA: New growth • TUMOUR: Swelling • ONCOLOGY: Study of cancer • CARCINOMA - epithelial cells • SARCOMA - connective tissue • OSTEOMA - bones

  4. Etiology of cancer • Multifactorial (Physical, Chemical, Genetic & Environmental) • chemical carcinogens • Radiating energy • Carcinogenic viruses • By any means DNA of host is affected

  5. Molecular Basis of cancer • Activation of protooncogenes to oncogenes • Viral insertion into chromosome • Chromosomal translocation • Gene amplification • Point mutation

  6. Tumor marker definition Biochemical substances synthesized & released by cancer cells or produced by host in response to cancerous substance.

  7. Applications • Screening • Diagnosis • Prognosis • Classification • Monitoring response of therapy • Follow up-Recurrence

  8. Characters of an ideal tumor marker • Analytical Criteria • High analytical sensitivity and specificity • Accuracy and Precision • Easy to measure at a low cost • Clinical Criteria • Disease sensitive (no false-negative results, ability to detect micrometastasis). • Disease specificity (no false-positive results, negative in disease-free individuals). • Associate only with particular cancer. • Levels should remain relatively constant and not fluctuate in patients with stable disease. • Correlate well with cure rate. • Should be undetectable or low in patients in complete remission.

More Related